Patents Examined by Blessing M. Fubara
  • Patent number: 10085943
    Abstract: Disclosed herein are a novel polymer, a thermosensitive carrier prepared using the same and use thereof. The novel polymer is essentially composed of a PEO-PPO-PEO block copolymer and silane.
    Type: Grant
    Filed: September 19, 2016
    Date of Patent: October 2, 2018
    Assignee: INSTITUTE OF NUCLEAR ENERGY RESEARCH, ATOMIC ENERGY COUNCIL, EXECUTIVE YUAN, R.O.C.
    Inventors: Po-Jung Chen, Mao-Chi Weng, Mei-Hui Wang, Chien-Chung Hsia
  • Patent number: 10085948
    Abstract: The invention relates to a method for ionic gelation on solids for encapsulating water-insoluble solids. The method uses negatively charged macromolecules and soluble salts of polyvalent cations as shell-forming materials having a high adsorption on the surface of the solid when subjected to thermal treatment. The shell-forming material represents at least 10% of the weight of the dry microcapsule obtained. The obtained microcapsule can be redispersed in water and treated by altering the environment thereof in order to be used as an encapsulating medium for water-soluble compounds and they can also be used as active ingredients and/or excipients in the production of pharmaceutical or nutraceutical compositions.
    Type: Grant
    Filed: August 21, 2014
    Date of Patent: October 2, 2018
    Assignee: Universidad de Antioquia (UDEA)
    Inventors: Herley Fernando Casanova, César Perez Zapata, César Restrepo, Johnatan Diosa Arango
  • Patent number: 10076509
    Abstract: Methods and compositions regarding nested nanoparticles comprising polymer nanoparticles encased in a cyclodextrin shell to facilitate sequence-specific drug release.
    Type: Grant
    Filed: May 2, 2016
    Date of Patent: September 18, 2018
    Assignee: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
    Inventor: Elvin Blanco
  • Patent number: 10076498
    Abstract: The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of manufacture, uses, and methods of treatment thereof.
    Type: Grant
    Filed: January 31, 2018
    Date of Patent: September 18, 2018
    Assignees: Purdue Pharma L.P., Purdue Pharmaceuticals L.P.
    Inventors: William H. McKenna, Richard O. Mannion, Edward P. O'Donnell, Haiyong H. Huang
  • Patent number: 10076499
    Abstract: The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of manufacture, uses, and methods of treatment thereof.
    Type: Grant
    Filed: January 31, 2018
    Date of Patent: September 18, 2018
    Assignees: Purdue Pharma L.P., Purdue Pharmaceuticals L.P.
    Inventors: William H. McKenna, Richard O. Mannion, Edward P. O'Donnell, Haiyong H. Huang
  • Patent number: 10071047
    Abstract: A method is provided which provides shine to hair comprising spraying a leave-on composition to hair with a particle size in the range of from about 0.01 ?m to about 10 ?m, wherein the resulting film at the dried hair is in the range of from about 100 nm to about 500 nm and more than 25% of the hair fibers are covered. The oil-in water polysiloxane emulsion shows a viscosity of less than 7 Pa*s and a pH value from about 4 to about 8. The emulsion comprises about 0.1% to about 10% by weight of a non-volatile polysiloxane fluid and from about 0.003% to about 0.6% by weight of a rheology modifier, wherein less than 0.015 g of the non-volatile polysiloxane fluid are applied per gram hair.
    Type: Grant
    Filed: October 28, 2016
    Date of Patent: September 11, 2018
    Assignee: The Procter & Gamble Company
    Inventors: Michael Lee Vatter, Kelly Rose Kroger Lyons, Timothy Woodrow Coffindaffer, Mikah Coffindaffer, Simran Preet Kaur, Timothy James Felts, Scott Edward Smith, Samuel Wolfe Stofel
  • Patent number: 10058568
    Abstract: In some embodiments, a composition and/or method may include a toxin binding system formulated for safe and effective mixture into various feed rations which are fed to monogastric and ruminant animals such as poultry, swine, cows, cattle, and fish, among others. The toxin binding system includes novel combinations of one or more of an organoclay, an activated hydrated sodium calcium aluminosilicate clay, and a synthetic hectorite clay. In some embodiments, the binding composition may include organoclay, bentonite, hectorite, Leonardite, and/or any combination thereof. The toxin binding complex may effectively bind mycotoxins, endotoxins and some pesticides in the animal's digestive system, preventing their absorption and the consequent damages to the animal. This binding action includes the T-2 toxin, which can start their damaging action in the animal's mouth, hence, offering protection from oral lesions.
    Type: Grant
    Filed: March 15, 2016
    Date of Patent: August 28, 2018
    Assignee: Special Nutrients, Inc.
    Inventor: Fernando Tamames, III
  • Patent number: 10047197
    Abstract: The present invention relates to the field of polymer chemistry and more particularly to multiblock copolymers and micelles comprising the same. Compositions herein are useful for drug-delivery applications.
    Type: Grant
    Filed: September 28, 2016
    Date of Patent: August 14, 2018
    Assignee: Intezyne Technologies, Inc.
    Inventors: Kevin Sill, Adam Carie
  • Patent number: 10039765
    Abstract: A vitamin supplement composition that includes a complex with enhanced bioavailability having a vitamin B complex, wherein the vitamin B complex includes: (a) a first vitamin, wherein the first vitamin comprises a form of vitamin B6; (b) a second vitamin, wherein the second vitamin comprises a form of vitamin B9; (c) a third vitamin, wherein the third vitamin comprises a form of vitamin B12; and (d) wherein the first vitamin, the second vitamin, and the third vitamin cooperate synergistically to enhance bioavailability of the same. The present invention further includes a method of administering a vitamin supplement composition to an individual having, for example, known or unknown MTHFR CT polymorphism.
    Type: Grant
    Filed: September 2, 2016
    Date of Patent: August 7, 2018
    Inventor: Michelle Ann Toothman
  • Patent number: 10039805
    Abstract: An infant food formulation having a vitamin complex with enhanced bioavailability, including a protein; a carbohydrate; a fat; and a vitamin B complex, wherein the vitamin B complex includes a vitamer of vitamin B6, a vitamer of vitamin B9, and a vitamer of vitamin B12.
    Type: Grant
    Filed: February 26, 2016
    Date of Patent: August 7, 2018
    Inventor: Michelle Ann Toothman
  • Patent number: 10028776
    Abstract: A composite implant comprising an injectable matrix material which is flowable and settable, and at least one reinforcing element for integration with the injectable matrix material, the at least one reinforcing element adding sufficient strength to the injectable matrix material such that when the composite implant is disposed in a cavity in a bone, the composite implant supports the bone.
    Type: Grant
    Filed: April 26, 2016
    Date of Patent: July 24, 2018
    Assignee: 206 Ortho, Inc.
    Inventors: Jeffrey A. D'Agostino, Andrew J. Carter, Arthur Watterson, Joseph P. Lane
  • Patent number: 10010612
    Abstract: The present invention relates to a risperidone sustained release delivery system for treatment of medical conditions relating delusional psychosis, schizophrenia, bipolar disorder, psychotic depression, obsessive-compulsion disorder, Tourette syndrome, and autistic spectrum disorders. The sustained release delivery system includes a flowable composition containing risperidone, a metabolite, or a prodrug thereof and an implant containing risperidone, a metabolite, or a prodrug thereof. The flowable composition may be injected into tissue whereupon it coagulates to become the solid or gel, monolithic implant. The flowable composition includes a biodegradable, thermoplastic polymer, an organic liquid, and risperidone, a metabolite, or a prodrug thereof.
    Type: Grant
    Filed: February 13, 2008
    Date of Patent: July 3, 2018
    Assignee: Indivior UK Limited
    Inventors: Eric Dadey, Qi Li, Christopher Lindemann
  • Patent number: 9992996
    Abstract: Aniline copolymers and the synthesis thereof for use as antimicrobial (antibacterial, antifungal or antiviral material) material of for the manufacture of antimicrobial objects, suitable for use in the health, food, packaging, water, paint, wood, textile, poultry, glass, paper, rubber, ceramic, seafood, sports, plastic and agricultural industries. The copolymer may be for example (A): where for example R3?H5—CO2H, —CO2Me, or —CO2Et. R is typically H or a C1-C6 alkyl, x is an integer between 1 and 0 and m indicates the degree of polymerization. Preferred copolymers are copolymers of aniline with 3-aminobenzoic acid, 2-aminobenzoic acid and ethyl 3-aminobenzoate.
    Type: Grant
    Filed: April 29, 2016
    Date of Patent: June 12, 2018
    Inventors: Marija Gizdavic-Nikolaidis, Allan J. Easteal, Srdjan Stepanovic
  • Patent number: 9980892
    Abstract: A skin care composition is described comprising water-soluble dye polymer comprising polymer backbone having negatively charged reactive dye substituent covalently bound thereto; and cosmetically acceptable carrier. The dye polymer is present in amount of 0.00001 to 0.1% in terms of reactive dye substituent by weight of the skin care composition. The composition is useful for providing cosmetic benefits such as skin lightening, evening skin tone and masking blemishes.
    Type: Grant
    Filed: March 10, 2015
    Date of Patent: May 29, 2018
    Assignee: Conopce, Inc.
    Inventors: Stephen Norman Batchelor, Peter Fairley, Naresh Dhirajlal Ghatlia, Adam John Limer, Xuezhi Tang, Jian-Rong Zhang
  • Patent number: 9961896
    Abstract: The present invention relates to a cleaning liquid, in particular a cleaning liquid for cleaning surfaces and/or for sanitizing water.
    Type: Grant
    Filed: August 29, 2014
    Date of Patent: May 8, 2018
    Assignee: JVS PRODUCTS LIMITED
    Inventor: Robert Scoones
  • Patent number: 9951015
    Abstract: Provided are certain pharmaceutical formulations of omecamtiv mecarbil and methods for their preparation and use.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: April 24, 2018
    Assignee: AMGEN INC.
    Inventors: Mingda Bi, Robert Kuehl
  • Patent number: 9951179
    Abstract: Eight-membered ring cyclic carbonates having an oxygen or an acylated nitrogen at position 6 were prepared by reaction of precursor diols with ethyl chloroformate. The cyclic carbonates undergo organocatalyzed ring opening polymerization. In one instance, the initial polymer formed comprises a carbonate repeat unit having a Boc-protected nitrogen in the polymer backbone. Deprotecting the nitrogen with acid forms a cationic carbonate repeat unit having a positive charged secondary ammonium nitrogen in the polymer backbone.
    Type: Grant
    Filed: February 20, 2017
    Date of Patent: April 24, 2018
    Assignees: International Business Machines Corporation, Agency For Science, Technology And Research
    Inventors: Mareva B. Fevre, James L. Hedrick, Victor W. L. Ng, Robert J. Ono, Shrinivas Venkataraman, Yi Yan Yang
  • Patent number: 9944752
    Abstract: The present invention relates to the field of polymer chemistry and more particularly to multiblock copolymers and micelles comprising the same. Compositions herein are useful for drug-delivery applications.
    Type: Grant
    Filed: March 10, 2016
    Date of Patent: April 17, 2018
    Assignee: Intezyne Technologies, Inc.
    Inventors: Kevin Sill, Tomas Vojkovsky, Adam Carie, Joseph Edward Semple, Hooshmand Sheshbaradaran
  • Patent number: 9944754
    Abstract: The present invention relates to the field of polymer chemistry and more particularly to multiblock copolymers and micelles comprising the same. Compositions herein are useful for drug-delivery applications.
    Type: Grant
    Filed: September 28, 2016
    Date of Patent: April 17, 2018
    Assignee: Intezyne Technologies, Inc.
    Inventors: Kevin Sill, Joseph Edward Semple, Tomas Vojkovsky
  • Patent number: 9918982
    Abstract: Dosage forms and drug delivery devices suitable for administration of pharmaceutical compounds and compositions, including the oral drug administration of compounds.
    Type: Grant
    Filed: November 3, 2016
    Date of Patent: March 20, 2018
    Assignee: Durect Corporation
    Inventors: Su Il Yum, Grant Schoenhard, Arthur J. Tipton, John W. Gibson, John C. Middleton, Roger Fu, Michael S. Zamloot